Full Press Release Details
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer.
IDYA
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
Key Takeaway: IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
Price reaction · baseline $26.64 (2024-11-15 close) · clean, no other IDYA news in the window
day 0 close · peak
-1.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma